Mutual Drug Company announces retiring CEO’s successor

DURHAM, N.C. — Mutual Drug Company recently announced that its board has chosen a successor for outgoing CEO David Moody, tapping a longtime company veteran to lead it. Hal Harrison, currently Mutual Drug Company’s VP operations will become CEO effective April 1, with Moody aiding with the transition before he retires. 

 

“Thanks to David’s leadership, Mutual is one of the top single source wholesalers in the country,” board chairman Gene Minton said. “We believe that Hal has the ability to grow what Mutual is today into an even more successful wholesaler in the future. He has shown the initiative and forward thinking that the Board feels will take our company to the next level in the current climate of the healthcare industry. Most importantly, he understands what Mutual means for independent pharmacy in our region.”

 

Harrison has been with Mutual Drug Company for 15 years and in that time has held such titles as VP Carolina Allied Pharmaceutical Sciences and director of purchasing and information systems.